What Is Dapagliflozin 5 mg And Sitagliptin 50 mg Used For? Type 2 Diabetes Control Explained

 Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets are used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes mellitus. The combination is usually prescribed when one medicine alone has not brought blood sugar to target. It pairs an SGLT2 inhibitor (dapagliflozin) with a DPP-4 inhibitor (sitagliptin), two medicines that work in different ways and do not depend on each other. ST-GLIPTIN DAPA 50/5 from Steris Healthcare gives doctors a metformin-free dual combination. This can be useful for patients who cannot tolerate metformin or who have a reason to avoid it. It is not for type 1 diabetes.

Why Is Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets Important?

Type 2 diabetes tends to progress. Over the years the pancreas makes less insulin, and insulin resistance continues. Poorly controlled sugar quietly damages the eyes, kidneys, nerves and blood vessels, and it raises the risk of heart disease. Many patients need a second or third medicine within a few years of diagnosis.

This combination is important because it supports control from two sides. Sitagliptin helps the body release insulin when sugar rises after meals. Dapagliflozin removes extra glucose through the urine, whether or not insulin is working well. Because the two actions are independent, together they can lower HbA1c more than either medicine alone. Both drugs also carry a low risk of hypoglycaemia when used without insulin or sulphonylureas, and a single tablet helps patients stay on their regimen. ST-GLIPTIN DAPA 50/5 is manufactured by Steris Healthcare, a WHO-GMP and ISO-certified manufacturer in Jaipur, which supports consistent quality in a long-term therapy.

Key Benefits of Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

What Are the Benefits of ST-GLIPTIN DAPA 50/5?

• Lowers fasting and after-meal blood sugar and HbA1c through two complementary actions
• Dapagliflozin may support modest weight loss and a small drop in blood pressure
• Dapagliflozin has shown heart and kidney protective benefits in clinical studies of people with type 2 diabetes
• Sitagliptin is generally weight-neutral and well tolerated
• Low risk of hypoglycaemia when not combined with insulin or sulphonylureas
• Gives a metformin-free option for patients who cannot take metformin
• One tablet replaces two, which simplifies the daily routine

Mechanism of Action

• Dapagliflozin blocks SGLT2 in the proximal tubules of the kidney. This reduces the reabsorption of filtered glucose, so the excess sugar leaves in the urine.
• Sitagliptin phosphate inhibits the enzyme DPP-4. This increases active incretin hormones (GLP-1 and GIP), which stimulate insulin release and reduce glucagon in a glucose-dependent way.

Together, they lower blood sugar through the kidney, the pancreas and the liver, without relying on a single pathway.

Dosage Guidelines for Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

Dosing must be decided by the treating doctor.

• Usual dose: as prescribed, commonly one tablet once or twice daily according to the approved label. Do not change the schedule yourself.
• How to take it: swallow the tablet whole with water, with or without food, at the same time every day.
• Fixed dose: the strengths are fixed, so it suits patients already stable on these dose levels. Patients who need other strengths should be prescribed the components separately.
• Kidney function: your doctor will check eGFR before and during treatment. Dose adjustment, or a different medicine, may be needed in moderate or severe kidney impairment.
• Monitoring: HbA1c, fasting and post-meal sugar, kidney function and blood pressure should be checked regularly.
• Stay hydrated and follow your diet and exercise plan.
• Missed dose: take it as soon as you remember, unless it is nearly time for the next dose. Do not double the dose.
• Before surgery or prolonged fasting: your doctor may ask you to pause it temporarily.

Side Effects of Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

Common effects include:

• Increased urination and thirst
• Genital itching or yeast infection
• Urinary tract infection
• Headache, sore throat or stuffy nose
• Nausea, stomach discomfort or loose stools
• Joint pain
• Mild weight loss or dizziness

Serious Side Effects of Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

Seek urgent medical help for:

• Nausea, vomiting, abdominal pain, unusual tiredness or breathing difficulty, even with normal sugar (ketoacidosis)
• Severe, persistent abdominal pain that may spread to the back, with or without vomiting (pancreatitis)
• Pain, redness, swelling or fever in the genital or anal area (Fournier’s gangrene, a rare but serious infection)
• Fever, flank pain or burning urine that does not settle (kidney infection)
• Dizziness, fainting or very low urine output (dehydration or kidney injury)
• Severe allergic reactions, with swelling of the face, lips or throat, rash or breathing difficulty
• Blisters on the skin (bullous pemphigoid)
• Severe, disabling joint pain

Available Substitutes for Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

Other brands containing the same combination of dapagliflozin and sitagliptin may be available, so ask your pharmacist for the same composition and strength. Doctors may also prescribe the two medicines as separate tablets, which allows each dose to be adjusted. Other dual combinations, such as dapagliflozin with metformin or sitagliptin with metformin, use different molecules and are not direct substitutes. Do not switch brands or components without medical advice.

Precautions & Warnings with Using Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets

• Do not use it in type 1 diabetes or diabetic ketoacidosis.
• Do not use it if you are allergic to dapagliflozin, sitagliptin or any ingredient in the tablet.
• Use caution, or avoid it, in severe kidney impairment or dialysis. Blood sugar lowering from dapagliflozin is reduced when kidney function is low.
• Use caution in people with a history of pancreatitis, or with gallstones or heavy alcohol use, which can raise pancreatitis risk.
• Use caution with recurrent genital or urinary infections, low blood pressure, older age or the use of diuretics, because of the risk of volume depletion.
• Stop it temporarily during acute illness with vomiting or poor intake, and before major surgery or prolonged fasting, as advised by your doctor.
• If you also take insulin or a sulphonylurea, the dose of that medicine may need to be reduced, to avoid hypoglycaemia.
• Limit alcohol. Keep the genital area clean and dry.
• Pregnancy and breastfeeding: it is generally not recommended, so speak to your doctor about alternatives such as insulin.
• Tell your doctor about all medicines you take, including diuretics, insulin, sulphonylureas and digoxin.

Conclusion

Dapagliflozin 5 mg And Sitagliptin Phosphate 50 mg Tablets, supplied as ST-GLIPTIN DAPA 50/5 by Steris Healthcare, combine two complementary mechanisms in one tablet to support better blood sugar control in adults with type 2 diabetes. As a metformin-free combination with a low risk of hypoglycaemia, it can suit patients who need an alternative. Used with a healthy diet, regular activity, good hydration and routine kidney and sugar monitoring, it can help patients reach their targets with a simpler daily regimen.